FDA Issues Safety Information for Pioglitazone-Containing Products; FDA Issues Public Health Advisory on Interferon Gamma 1-b (Actimmune)

Username:....................

Password:....................

Policy Library
Click here for
20,000 policy &
form templates

Home яПН Browse All Libraries яПН Food and Drug Administration яПН FDA Issues Safety Information for Pioglitazone Containing Products FDA Issues Public Health Advisory on Interferon Gamma 1 b Actimmune

Subject:

FDA Issues Safety Information for Pioglitazone-Containing Products; FDA Issues Public Health Advisory on Interferon Gamma 1-b (Actimmune)

Category:

Food and Drug Administration (FDA)

Published:

Tue, 13 Mar 2007 - 12:00 am

Actos (pioglitazone) Tablets ACTOplus met (pioglitazone and metformin hydrochloride) Tablets Duetact (pioglitazone and glimepiride) Tablets Audience: Endocrinologists, other healthcare professionals, consumers The FDA and Takeda Pharmaceuticals North America, Inc have notified healthcare professionals of recent safety data concerning pioglitazone-containing products, i.e., ACTOS Tablets, ACTO plus metЎ (pioglitazone HCI and metformin hydrochloride) Tablets, and duetact TM (pioglitazone HCI...

The full article is available to StayAlert subscribers. Click here for a free trial subscription.

RESOURCES:

Customizable Documents and Tools:

Policies, forms and resources are available to subscribers only. Get free trial subscription.

External Links:

External references are available to subscribers only. Get free trial subscription.

StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions.

Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards.